ロード中...
Beta-blockers or Digoxin for Atrial Fibrillation and Heart Failure?
In patients with atrial fibrillation (AF) and heart failure (HF) with or without systolic dysfunction, either rhythm control or rate control is an acceptable primary therapeutic option. If a rate control strategy is chosen, treatment with a beta-blocker is almost always required to achieve rate cont...
保存先:
| 出版年: | Card Fail Rev |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Radcliffe Cardiology
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5490978/ https://ncbi.nlm.nih.gov/pubmed/28785450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/cfr.2015:28:2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|